Skip to content

The Efficacy of Compound Honey Syrup in Cystic Fibrosis Patients

The efficacy of Compound Honey Syrup on Fractional Exhalation Nitric Oxide (FeNO) Changes, Pulmonary Symptoms and Body Mass Index (BMI) in Cystic Fibrosis Patients

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200103045989N1
Enrollment
40
Registered
2021-12-21
Start date
2021-11-06
Completion date
Unknown
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic Fibrosis. ICD-10

Interventions

Intervention 1: Intervention group: Includes patients with cystic fibrosis over 6 years of age referred to the pulmonary clinic of Mofid Children's Hospital who are able to perform FeNO test.Lung exam

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients with cystic fibrosis over 6 years who are able to perform FeNO test.

Exclusion criteria

Exclusion criteria: Patients with cystic fibrosis under 6 years Patients in need of hospitalization Patients who have exacerbation (increased cough, sputum, fever and need to be hospitalized) Patients with underlying diseases such as allergic bronchopulmonary aspergillosis, heart failure, tuberculosis Patients with another acute illness during treatment Patients who are allergic to any component of the compound honey syrup Patients requesting exclusion Patients unable to perform FeNO test.

Design outcomes

Primary

MeasureTime frame
FeNO. Timepoint: At the beginning of the study and 12 weeks after the administration of the compound honey syrup. Method of measurement: FeNO Testing Device.;Body Mass Index. Timepoint: At the beginning of the study and 12 weeks after the administration of the compound honey syrup. Method of measurement: Weight / Squared Height.;Pulmonary Symptoms. Timepoint: At the beginning of the study and 12 weeks after the administration of the compound honey syrup. Method of measurement: CFQ-R questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNafise Fadavi

Shahid Beheshti University of Medical Sciences

nf.fadavi@yahoo.com+98 31 3230 2382

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026